Skip to content

N/A (REF 50-601XL)Recalls & reported problems

Stryker Sustainability Solutions, Inc. · MyoSure XL Tissue Removal Device for Fluent · Class 2

Adverse event reports
8
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 07613327507140), received between Oct 27, 2022 and Jun 8, 2026 — classified as 5 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Dull, Blunt” (6 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Dull, Blunt6
  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions8

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 8, 2026

    MYOSURE HANDPIECE BEGAN TO JERK AND MOVE BACK AND FORTH VIOLENTLY. THE RESIDENT HELD HER HAND STEADY AND FIRMLY TO KEEP ABSOLUTE CONTROL OF THE HANDPIECE. THE CIRCULATOR OPENED A 2ND MYOSURE HANDPIECE, WHICH DID THE SAME THING.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25428180 ↗
  • MalfunctionMar 4, 2026Dull, Blunt

    IT WAS REPORTED THAT THE MYOSURE BLADE WAS STUCK IN THE OPEN POSITION FORM THE BEGINNING. THERE WAS NO PATIENT INJURY, MEDICAL INTERVENTION, OR EXTENDED PROCEDURE TIME REPORTED. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24514361 ↗
  • MalfunctionAug 11, 2025Break; Break

    IT WAS REPORTED THAT THE MYOSURE DEVICE WOULD NOT DISSECT TISSUE AND THE CASE WAS COMPLETED WITH AN OEM DEVICE. AS REPORTED, THE USER WAS TRYING TO GRAB SOMETHING OUTSIDE OF THE IFU PARAMETERS. THERE WAS NO PATIENT INJURY OR MEDICAL INTERVENTION AND EXTENDED PROCEDURE TIME REPORTED WAS MINIMAL. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22779350 ↗
  • InjuryOct 27, 2022Dull, Blunt; Dull, Blunt

    IT WAS REPORTED THAT THE SURGEON HAD TO OPEN FIVE DIFFERENT MYOSURE DEVICES FOR A PROCEDURE BECAUSE THEY WERE NOT SHARP ENOUGH. THE SURGEON WAS UNABLE TO COMPLETE SURGERY BEFORE MAXING PATIENT FLUID DEFICIT OF 2500 ML NACL. THE SURGEON STATED ABOUT 70% OF THE LARGE UTERINE MYOMA WAS REMOVED, REQUIRING THE PATIENT TO RETURN FOR ANOTHER SURGERY TO COMPLETE THE REMOVAL OF MYOMA. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15686133 ↗
  • InjuryOct 27, 2022Dull, Blunt; Dull, Blunt

    IT WAS REPORTED THAT THE SURGEON HAD TO OPEN FIVE DIFFERENT MYOSURE DEVICES FOR A PROCEDURE BECAUSE THEY WERE NOT SHARP ENOUGH. THE SURGEON WAS UNABLE TO COMPLETE SURGERY BEFORE MAXING PATIENT FLUID DEFICIT OF 2500 ML NACL. THE SURGEON STATED ABOUT 70% OF THE LARGE UTERINE MYOMA WAS REMOVED, REQUIRING THE PATIENT TO RETURN FOR ANOTHER SURGERY TO COMPLETE THE REMOVAL OF MYOMA. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15686028 ↗
  • InjuryOct 27, 2022Dull, Blunt; Dull, Blunt

    IT WAS REPORTED THAT THE SURGEON HAD TO OPEN FIVE DIFFERENT MYOSURE DEVICES FOR A PROCEDURE BECAUSE THEY WERE NOT SHARP ENOUGH. THE SURGEON WAS UNABLE TO COMPLETE SURGERY BEFORE MAXING PATIENT FLUID DEFICIT OF 2500 ML NACL. THE SURGEON STATED ABOUT 70% OF THE LARGE UTERINE MYOMA WAS REMOVED, REQUIRING THE PATIENT TO RETURN FOR ANOTHER SURGERY TO COMPLETE THE REMOVAL OF MYOMA. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15686024 ↗
  • InjuryOct 27, 2022Dull, Blunt; Dull, Blunt

    IT WAS REPORTED THAT THE SURGEON HAD TO OPEN FIVE DIFFERENT MYOSURE DEVICES FOR A PROCEDURE BECAUSE THEY WERE NOT SHARP ENOUGH. THE SURGEON WAS UNABLE TO COMPLETE SURGERY BEFORE MAXING PATIENT FLUID DEFICIT OF 2500 ML NACL. THE SURGEON STATED ABOUT 70% OF THE LARGE UTERINE MYOMA WAS REMOVED, REQUIRING THE PATIENT TO RETURN FOR ANOTHER SURGERY TO COMPLETE THE REMOVAL OF MYOMA. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15685990 ↗
  • InjuryOct 27, 2022Dull, Blunt; Dull, Blunt

    IT WAS REPORTED THAT THE SURGEON HAD TO OPEN FIVE DIFFERENT MYOSURE DEVICES FOR A PROCEDURE BECAUSE THEY WERE NOT SHARP ENOUGH. THE SURGEON WAS UNABLE TO COMPLETE SURGERY BEFORE MAXING PATIENT FLUID DEFICIT OF 2500 ML NACL. THE SURGEON STATED ABOUT 70% OF THE LARGE UTERINE MYOMA WAS REMOVED, REQUIRING THE PATIENT TO RETURN FOR ANOTHER SURGERY TO COMPLETE THE REMOVAL OF MYOMA. THESE ARE COMMONLY USED DEVICES THAT ARE READILY AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15685978 ↗

Other HYSTEROSCOPE (AND ACCESSORIES) devices

All HYSTEROSCOPE (AND ACCESSORIES) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.